COO vs DBVT vs ALKS vs BLCO

For growth investors, Bausch + Lomb Corporation (BLCO) is the stronger pick with 6.

5% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate The Cooper Companies, Inc. (COO) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.

8x versus The Cooper Companies, Inc. at 32. 7x. On forward P/E, The Cooper Companies, Inc. is actually cheaper at 13. 2x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: COO returned +57. 9% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Cooper Companies, Inc.

(COO) is the lower-risk stock at 0. 93β versus Bausch + Lomb Corporation's 1. 39β — meaning BLCO is approximately 50% more volatile than COO relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 82% for Bausch + Lomb Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Bausch + Lomb Corporation (BLCO) is pulling ahead at 6.

5% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: The Cooper Companies, Inc. grew EPS -4. 6% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, BLCO leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -7. 1% for Bausch + Lomb Corporation — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, The Cooper Companies, Inc.

(COO) trades at 13. 2x forward P/E versus 20. 1x for Bausch + Lomb Corporation — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, The Cooper Companies, Inc.

(COO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93)). Both have compounded well over 10 years (COO: +57. 9%, BLCO: -20. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.